REQUEST A DEMO
Total
USD $0.00
View basket Checkout now
Search more companies

Zhejiang Starry Pharmaceutical Co., Ltd. (China)

Main Activities: Pharmaceutical and Medicine Manufacturing
Full name: Zhejiang Starry Pharmaceutical Co., Ltd. Profile Updated: November 16, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2023 Available in: English & Chinese Download a sample report

Zhejiang Starry Pharmaceutical Co., Ltd researches, develops, and manufactures active ingredient and intermediate X-CT non-ionic contrast agent series and Fluoroquinolones series. The company was founded in 1997 and is headquartered in Taizhou City, China.

Headquarters
No. 9, Fengxi West Road, Modern Industrial Cluster, Xianju County, Taizhou City, Zhejiang Province
Taizhou; Zhejiang; Postal Code: 317306

Contact Details: Purchase the Zhejiang Starry Pharmaceutical Co., Ltd. report to view the information.

Website: http://www.starrypharm.com

Basic Information
Total Employees:
Purchase the Zhejiang Starry Pharmaceutical Co., Ltd. report to view the information.
Outstanding Shares:
Purchase the Zhejiang Starry Pharmaceutical Co., Ltd. report to view the information.
Registered Capital:
Purchase the Zhejiang Starry Pharmaceutical Co., Ltd. report to view the information.
Financial Auditors:
Purchase the Zhejiang Starry Pharmaceutical Co., Ltd. report to view the information.
Incorporation Date:
September 15, 1997
Key Executives
Purchase this report to view the information.
Chairman
Purchase this report to view the information.
Chairman of the Supervisory Board
Purchase this report to view the information.
Director
Purchase this report to view the information.
Director
Purchase this report to view the information.
General Manager
Ownership Details
Purchase this report to view the information.
14.08%
Purchase this report to view the information.
13.71%
Purchase this report to view the information.
1.86%
Purchase this report to view the information.
1.64%
Purchase this report to view the information.
1.64%
Subsidiaries
Shanghai Bond Pharmaceutical Technology Co., Ltd.
100%
Shanghai Stellite Pharmaceutical Co., Ltd.
100%
Stellite Investment (Hong Kong) Co., Ltd.
100%
Company Performance
Financial values in the chart are available after Zhejiang Starry Pharmaceutical Co., Ltd. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency CNY. Absolute financial data is included in the purchased report.
Net sales revenue
10.65%▲
Total operating revenue
10.23%▲
Operating profit (EBIT)
-62.03%▼
Net Profit (Loss) for the Period
-76.59%▼
Total assets
3.07%▲
Total equity
51.52%▲
Operating Profit Margin (ROS)
-1.75%▼
Net Profit Margin
-1.91%▼
Return on Equity (ROE)
-1.89%▼
Debt to Equity Ratio
-79.86%▼
Quick Ratio
0.02%▲
Cash Ratio
-0%

Similar companies

Sinopharm Group Company Limited
 
Shanghai Pharmaceuticals Holding Co.,Ltd
Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited
 
Nanjing Pharmaceutical Company Limited
Chongqing Zhifei Biological Products Co.,Ltd.
 
Hubei Biocause Pharmaceutical Co.,Ltd.
Jiangsu Lianhuan Pharmaceutical Co.,Ltd.
 
Jinhe Biotechnology Co.,Ltd.
Guilin Sanjin Pharmaceutical Co., Ltd
 
Cathay Biotech Inc.
Xiamen Amoytop Biotech Co., Ltd.
 

Related EMIS Industry Reports

To view more information, Request a demonstration of the EMIS service

USD 29.95
Buy this company report
Need ongoing access to company, industry or country information?
Request a demo